The St. Jude Medical Infinity™ Deep Brain Stimulation (DBS) system with directional lead technology is designed to help patients with Parkinson’s disease or essential tremor gain control of their ...

Medical device major Medtronic plc’s MDT Activaportfolio of Deep Brain Stimulation (DBS) neurostimulators’ systems recently won the U.S. FDA approval for conditional use in full-body Magnetic ...

Boston Scientific (($BSX)) announced an update on their ongoing clinical study. Study Overview: The Vercise DBS Registry, ...

NEW ORLEANS — A new multiple-source system for deep-brain stimulation (DBS) in patients with Parkinson's disease proved effective in the randomized, double-blind INTREPID trial, meeting its primary ...

The US Food and Drug Administration (FDA) has approved a new software upgrade for Abbott's Infinity deep-brain stimulation (DBS) system used in patients with Parkinson's disease and essential tremor, ...

Boston Scientific (($BSX)) announced an update on their ongoing clinical study. Study Overview: The Vercise™ DBS Dystonia Prospective Study, ...

Medtronic plc MDT recently announced receipt of the FDA’s approval for its Percept PC Deep Brain Stimulation (“DBS”) system. The inclusion of the BrainSense technology with the Percept PC DBS system ...

Boston Scientific Corporation BSX has received CE Mark approval for use of the GUIDE™ DBS System, the world's first deep brain stimulation (DBS) visualization system. GUIDE DBS provides clinicians ...

St. Jude Medical Inc.STJ recently announced the receipt of CE Mark approval for its Infinity Deep Brain Stimulation ("DBS") System and directional DBS lead, allowing sale in the European market. The ...

India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc, today announced the launch of the Percept PC – Deep Brain Stimulation (DBS) system for patients with Parkinson’s disease, ...